Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report
Washington, D.C. science advisor Ilse Peterson co-authored an article in the Journal of Aerosol Medicine and Pulmonary Drug Delivery titled, "Equivalence Considerations for Orally Inhaled Products for Local Action - ISAM/IPAC-RS European Workshop Report. The article discusses currently regulatory approaches in Europe, the United States and Canada, presents points of consensus as well as ongoing debate in the four major areas relating to orally inhaled products.
More information: Report for the 2010 European Workshop on Equivalence Determinations for Orally Inhaled Drugs for Local Action
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
Meet the Authors
